Dr. Thomas Denton Demark, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 3 Cooper Plz, Suite 307, Camden, NJ 08103 Phone: 856-342-2328 Fax: 856-541-6137 |
Nicholas Matthew Adamo, MD Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 1 Cooper Plz, Camden, NJ 08103 Phone: 800-826-6737 |
Pamela Szeeley, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 3 Cooper Plz, Suite 307, Camden, NJ 08103 Phone: 856-968-7433 |
John E Bevilacqua, MD Psychiatry & Neurology - Neurology Medicare: Medicare Enrolled Practice Location: 3 Cooper Plz, Suite 320, Camden, NJ 08103 Phone: 856-616-1337 |
Dr. Michael H Goodman, MD Psychiatry & Neurology - Neurology with Special Qualifications in Child Neurology Medicare: Medicare Enrolled Practice Location: 3 Cooper Plz, Suite 200, Camden, NJ 08103 Phone: 856-342-2001 Fax: 856-968-2499 |
Yingcheng Xu, M.D. Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 3 Cooper Plz Rm 307, Camden, NJ 08103 Phone: 856-342-2328 |
Teresa J Humaran, MD Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 3 Cooper Plz, Suite 307, Camden, NJ 08103 Phone: 856-342-2328 Fax: 856-541-6137 |
Dr. Evren Burakgazi-dalkilic, M.D. Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 3 Cooper Plz, Suite 215, Camden, NJ 08103 Phone: 856-342-2445 Fax: 856-964-0504 |
Consuelo C Cagande, MD Psychiatry & Neurology - Child & Adolescent Psychiatry Medicare: Medicare Enrolled Practice Location: 3 Cooper Plz, Suite 307, Camden, NJ 08103 Phone: 856-342-2328 Fax: 856-541-6137 |
Amy Colcher, MD Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 3 Cooper Plz, Suite 215, Camden, NJ 08103 Phone: 856-356-2445 |
Miss Andrea Lynne Dimaio, DO Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 1 Cooper Plaza, Suite 307, Camden, NJ 08103 Phone: 856-342-2328 |
Yunis Mayasi, M.D. Psychiatry & Neurology - Neurocritical Care Medicare: Accepting Medicare Assignments Practice Location: 1 Cooper Plz, Camden, NJ 08103 Phone: 856-968-8282 |
Dr. Antonia Phillip, MD, MBA Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 1 Cooper Plz, Camden, NJ 08103 Phone: 856-342-2000 |
Dr. Garrett Rossi, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 1 Cooper Plz, Camden, NJ 08103 Phone: 856-342-2000 |
Arooj Latif, Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 1 Cooper Plz, Camden, NJ 08103 Phone: 800-826-6737 |
R Rao Gogineni, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 3 Cooper Plz, Suite 307, Camden, NJ 08103 Phone: 856-342-2328 Fax: 856-541-6137 |
Dr. Olga Regina Thon, M.D. Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 3 Cooper Plz Rm 104, Camden, NJ 08103 Phone: 856-968-8695 |
Eric Nagele, Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 1 Cooper Plz, Camden, NJ 08103 Phone: 856-342-2000 |
Dr. Ukpere Daniel Nimtor, MD; MSN Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 1 Cooper Plz, Camden, NJ 08103 Phone: 856-757-7853 |
Sindhura Kunaparaju, Psychiatry & Neurology - Child & Adolescent Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 1 Cooper Plaza, Camden, NJ 08103 Phone: 856-342-2000 |
News Archive
VOA News reports on a March 20 panel meeting in Washington, D.C., that highlighted the contributions of corporations and non-governmental organizations (NGOs) to the Global Fund to Fight AIDS, Tuberculosis and Malaria.
Each year, hundreds of millions of public and private dollars are spent on medical research to improve the health of children – yet parents have little input regarding how those dollars should be spent.
MAP Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has informed the Company that a second pivotal efficacy study is not required for the Company's LEVADEX(TM) new drug application (NDA) submission for the acute treatment of migraine. The Company announced in May 2009 that the efficacy portion of its Phase 3 FREEDOM-301 clinical study of LEVADEX met all four primary endpoints. The Company had previously anticipated initiating a second pivotal efficacy study in the first quarter of 2010.
Inter Press Service examines gender discrimination and mortality in India, writing, "Global infant and child mortality rates have been on the decline in recent years, with a large portion of the world seeing young girls experiencing higher rates of survival than young boys; but India remains the exception to this positive trend."
› Verified 8 days ago